For US Healthcare Professionals Only

Currently Viewing: 

Formulary Information for Sotalol IV

The essentials to streamline safe and effective use of Sotalol IV within your hospital or health system.

Sotalol IV-to-oral protocol may shift cases from inpatient to outpatient. Make an informed decision about including Sotalol IV on your hospital’s formulary drug list with the resources on this page.

Information on Sotalol IV for formulary consideration

Case Study: Advantages of Using Sotalol IV as a Loading Dose

Brad Knight, MD discusses the advantages of Sotalol IV at his practice for both patients and nursing staff. Dr. Knight's appearance in this video was sponsored by AltaThera

Expedited Loading with Intravenous Sotalol and Mobile ECG Monitoring – Primary Results of the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry.

Steinberg BA, Deering TF, Holubkov R, et al. Expedited Loading with Intravenous Sotalol and Mobile ECG Monitoring - Primary Results of the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry. Poster Presented at Heart Rhythm Society 2023; May 19 -21, 2023; New Orleans, LA.

Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay.

Liu AY, Charron J, Fugaro D, et al.  Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay. J Cardiovasc Electrophysiol. 2023; 34:502‐506. doi:10.1111/jce.15819

Download the Sotalol IV Formulary Kit

Your one-stop document for considering Sotalol IV for your hospital’s formulary drug list, including essential drug information, dosing, warnings and contraindications, coding, ordering information, and more.

Considerations When Implementing Sotalol IV In Your Practice

Brad Knight, MD discusses some considerations when integrating Sotalol IV into your hospital workflow. Dr. Knight's appearance in this video was sponsored by AltaThera. 

Case Study: Advantages of Using Sotalol IV as a Loading Dose

Brad Knight, MD discusses the advantages of Sotalol IV at his practice for both patients and nursing staff. Dr. Knight's appearance in this video was sponsored by AltaThera

Review of a Sotalol IV Retrospective Study Presented at ACC.24

We explored a retrospective study on Sotalol IV presented at ACC.24 by Keturah DelGrosso, PharmD, BCPS

An Overview of the Sotalol IV PEAKS Registry

We discussed the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry with T. Jared Bunch, MD.

Expedited Loading with Intravenous Sotalol and Mobile ECG Monitoring – Primary Results of the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry.

Steinberg BA, Deering TF, Holubkov R, et al. Expedited Loading with Intravenous Sotalol and Mobile ECG Monitoring - Primary Results of the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry. Poster Presented at Heart Rhythm Society 2023; May 19 -21, 2023; New Orleans, LA.

Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay.

Liu AY, Charron J, Fugaro D, et al.  Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay. J Cardiovasc Electrophysiol. 2023; 34:502‐506. doi:10.1111/jce.15819

More resources for the hospital formulary review process

Explore next steps to use Sotalol IV at your institution.

Intro to Sotalol IV

Understand how Sotalol IV could potentially benefit your hospital.

Contact Us

Ask a question or schedule a meeting about Sotalol IV

Workflow Integration

Learn best practices for integrating Sotalol IV into your clinical workflow.

This website is intended for US healthcare professionals only.

By selecting an option below, you certify that you are a licensed US healthcare professional and wish to view information regarding Sotalol IV (sotalol hydrochloride injection). 

I’m using Sotalol IV in…

View adult website

View pediatric website

Highlights of Prescribing Information

Boxed Warning, Indications, and Important Safety Information

WARNING: LIFE THREATENING PROARRHYTHMIA

Sotalol can cause life threatening ventricular tachycardia associated with QT interval prolongation. To minimize the risk of drug induced arrhythmia, initiate or uptitrate intravenous sotalol in a facility that can provide continuous electrocardiographic monitoring and cardiac resuscitation [see Dosage and Administration (2.3) and Warnings and Precautions (5.1)].
Do not initiate intravenous sotalol therapy if the baseline QTc is longer than 450 ms. If the QTc prolongs to 500 ms or greater, reduce the dose or discontinue.